Alice Panchaud

Clinical Pharmacist with a special interest on safety and effectiveness of drugs during pregnancy and lactation.

[PharmaBern @PharmaBern]

Welcome to PharmaBern, the virtual community in Pharmaceutical Sciences and Pharmacy @unibern! If you visit https://t.co/AYpUCvq6f5 you will get to know all our interfaculty activities in teaching, research & innovation at UniBE! #pharmabern @DCBPunibern @MedFacultyUniBE

[Alice Panchaud @AlicePanchaud]

@MedsInPregIRL I would like to thank @MedsInPregIRL to give me the opportunity to speak @ENTISOfficial meeting 2023 about this very important topic that is risk communication of the available evidence of benefit and risks of drugs in pregnancy at the era of big data.

[Ruth Dobson @drruthdobson]

Our latest review is live in @eClinicalMed - we discuss the pressing need to capture longer term data around exposure to medications for neurological disease in pregnancy. We know much more about the short-term effects, but there remains an evidence gap https://t.co/cWZC5CTcLc

[ENTISOfficial @ENTISOfficial]

Fantastic to have @MotherToBaby representation with us at #ENTISDublin23!!!

[Irish Medicines in Pregnancy Service (IMPS) @MedsInPregIRL]

Important take home messages & the concept of the clinician as translator of the available evidence on #MedsInPregnancy

[Irish Medicines in Pregnancy Service (IMPS) @MedsInPregIRL]

Prof @AlicePanchaud giving an excellent overview of the challenges around interpreting & communicating findings from #Pharmacoepi studies in pregnancy. New challenges with the Big Data paradox #MedsInPregnancy #ENTISDublin23

[Irish Medicines in Pregnancy Service (IMPS) @MedsInPregIRL]

Engaging and insightful panel discussion on risk communication and information provision on #MedsInPregnancy to wrap up this session of #ENTISDublin23 with @AlicePanchaud @mc_climent @drjendonnelly @StephPadberg @meogan @SMHopkins

[IMIConcePTION @IMIConcePTION]

JUST PUBLISHED: Safety of medicines during breastfeeding – from case report to modeling: a contribution from the ConcePTION project 👇

https://t.co/lNuBuuERQp

[Frontiers @FrontiersIn]

Datamama: the first #pregnancy app to address the needs of both patients and researchers.

Read this new article published in Frontiers in Drug Safety and Regulation @FrontDrugDDS by @AlicePanchaud and colleagues from @CHUVLausanne and @unibern ⬇

#eHealth #pharmacoepidemiology

[Frontiers in Drugs Portfolio @FrontDrugDDS]

New Research: Editorial: Computational methods and systems to support decision making in pharmacovigilance https://t.co/0j6uMSd7nP #DrugSafetyandRegulation

[Frontiers in Drugs Portfolio @FrontDrugDDS]

New Research: Specialty grand challenge editorial innovative approaches for pharmacoepidemiologic research in pregnancy: Shifting the paradigm of Thalidomide’s impact on pregnant women https://t.co/QK92XBHZgS #DrugSafetyandRegulation

[Frontiers in Drugs Portfolio @FrontDrugDDS]

We are very pleased to announce Dr. Alice Panchaud from the University of Bern as our new Specialty Chief Editor of #maternalfetalmedicine for Frontiers in Drug Safety and Regulation!

Submissions are NOW Open!

Discover more: https://t.co/LZNNu1X7At

[Alice Panchaud @AlicePanchaud]

😢

[UKTIS bumps @medsinpregnancy]

bumps leaflets empower women to make informed decisions about medicine use in #pregnancy https://t.co/LHLXZD8TIv

[Emeline Newhouse @emynewhouse]

Prolongation de l’étude sur la surveillance du vaccin anti-COVID-19 (booster) jusqu’au 30/11/2022 - Groupement Romand de la Société Suisse de Gynécologie et Obstétrique https://t.co/KjdQbg2lGo

[Alice Panchaud @AlicePanchaud]

@Per_Damkier I moved on the same server as you @Per_Damkier. On the waiting list…

[Saskia Middeldorp @MiddeldorpS]

Free access to the full @Highlow paper: https://t.co/dh826uOQRM Valid until December 17, 2022, welcome to read or download. No sign up, registration or fees are required.